Benziger Bensam

Benziger Bensam practices at North Shore University Hospital in Manhasset, New York, part of Northwell Health.

Benziger Bensam's NPI, 1578011540, was assigned on September 19, 2016. Benziger Bensam graduated from Zhejiang Medical University in 2013. Benziger Bensam holds New York license 314678.

Benziger Bensam's primary practice is North Shore University Hospital, at 300 Community Drive, Manhasset, NY 11030 in Nassau County. The practice phone is (516) 562-0100.

Benziger Bensam's primary practice is North Shore University Hospital in Manhasset, New York, part of Northwell Health. Benziger Bensam is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck.

Dmand AI tracks the electronic health record (EHR) system at each site where Benziger Bensam practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Benziger Bensam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Benziger Bensam is licensed in New York.

CMS data shows 211 Medicare services from Benziger Bensam across 3 procedure codes in 2024, for 89 Medicare patients. Medicare paid $30,615 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Benziger Bensam in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Benziger Bensam's median patient age at 64, with 58% women.

In 2019, Benziger Bensam wrote 40 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $502 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Benziger Bensam for performance year 2024, reported through an alternative payment model (APM). Benziger Bensam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Benziger Bensam in 2018. Benziger Bensam's most frequent co-authors are David E. Ledoux, MD, Paulomi Kadakia Bhalla, MD and Joshua Burshtein, MD.

CMS Open Payments shows 1 general payment to Benziger Bensam from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.

Benziger Bensam graduated from Zhejiang Medical University in 2013.